HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries
GPO Prohibition
Subscribe to GPO Prohibition's Posts

This Week in 340B: May 27 – June 2, 2025

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Other; Contract Pharmacy; HRSA Audit Process; GPO Prohibition

  • In a case against the Health Resources and Services Administration’s (HRSA) challenging its certification of a group of entities as 340B-eligible, the government filed a reply in support of its partial motion to dismiss. 
  • In a case by a covered entity challenging the government’s decision to allow a manufacturer’s audit, the government filed a motion to dismiss.
  • In a case by a covered entity against the government, the court granted the covered entity motion for leave to file a response to the intervenors’ amicus brief.
  • A drug manufacturer filed a complaint challenging a Hawaii state law governing contract pharmacy arrangements.
  • In a case challenging HRSA’s policy limiting the circumstances in which covered entities can use their group purchasing arrangements to purchase non-340B drugs, the plaintiff filed a combined reply in support of its motion for summary judgment and opposition to defendant’s cross motion for summary judgment.
  • In three cases challenging state laws in Tennessee, [...]

    Continue Reading



read more

This Week in 340B: May 6 – 12, 2025

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; GPO Prohibition; Anti-Trust; Other

  • A group of commonly-owned drug manufacturers filed a complaint against the Tennessee attorney general to challenge a state law governing contract pharmacy arrangements.
  • In a case challenging a Nebraska state law governing contract pharmacy arrangements, a group of amici filed an amici curiae brief in support of the defendant’s motion to dismiss.
  • In a case challenging the Health Resources and Services Administration’s (HRSA) policy limiting the circumstances in which covered entities can use their group purchasing arrangements to purchase non-340B drugs, the defendant filed a cross motion for summary judgment and opposition to plaintiff’s motion for summary judgment.
  • In an appealed case challenging a Louisiana law governing contract pharmacy arrangements, the intervenor-defendant filed a motion for leave to file a sur-reply to appellant’s reply brief.
  • In an anti-trust class action case, the defendant filed a motion to dismiss plaintiff’s amended complaint.
  • In a case challenging a Missouri state law governing contract pharmacy arrangements, the defendants filed a [...]

    Continue Reading



read more

STAY CONNECTED

TOPICS

ARCHIVES

Chambers 2021 Top Ranked
U.S. News Law Firm of the Year 2022 Health Care Law
LEgal 500 EMEA top tier firm 2021
Legal 500 USA top tier firm